Back to Gene
BDNF gene
Reviewed by Medicinsk Expert•Last updated: 2026-10-22•Gene

BDNF gene

The BDNF gene provides instructions for making a protein that promotes the survival, growth, and maintenance of nerve cells in the brain and spinal cord.

Normal Function

The BDNF gene provides instructions for making a protein called brain-derived neurotrophic factor. This protein is active at the connections between nerve cells (synapses), where it helps regulate synaptic plasticity—the ability of synapses to change and adapt in response to experience, which is vital for learning and memory. The protein is also found in regions of the brain that control eating, drinking, and body weight.

Health Conditions Related to Genetic Changes

WAGRO syndrome

WAGRO syndrome is a variant of WAGR syndrome, a disorder named for its main features: Wilms tumor (a kidney cancer), aniridia (an eye problem), genitourinary anomalies, and intellectual disability. WAGRO syndrome also includes obesity.

  • The BDNF gene is located in a region of chromosome 11 that is often deleted in WAGRO syndrome.
  • The loss of the BDNF gene is responsible for weight gain that begins in childhood.
  • Individuals with WAGRO syndrome may have an increased risk of neurological problems, such as autism spectrum disorder and intellectual disability, compared to those with WAGR syndrome.

Other disorders

Genetic variations (polymorphisms) in the BDNF gene have been associated with an increased risk of psychiatric disorders, including:

  • Bipolar disorder
  • Anxiety
  • Eating disorders

Most research has focused on the Val66Met (or V66M) polymorphism, where the amino acid valine is replaced by methionine at position 66. This change impairs the protein's ability to function, though it remains unclear exactly how these genetic changes relate to the development of these complex psychiatric conditions.

Frequently Asked Questions

Peripheral BDNF measurements are highly variable and not yet validated as a reliable biomarker for psychiatric or metabolic disease severity. Current research is exploring correlations, but routine clinical use of blood BDNF levels is not supported at this time.
BDNF plays a key role in regulating appetite and energy expenditure. In WAGRO syndrome, deletion of the BDNF gene leads to hyperphagia and early‑onset obesity. While there is no gene‑specific therapy, structured dietary plans, regular physical activity, and behavioral interventions can mitigate weight gain and improve metabolic outcomes.
The Val66Met variant has been linked in some studies to higher susceptibility to mood disorders, but the effect size is modest and influenced by environmental factors. Routine clinical testing for this polymorphism is not recommended because it does not change standard treatment plans; instead, clinicians focus on clinical assessment and evidence‑based therapies.
There is no drug that directly increases BDNF levels. However, selective serotonin reuptake inhibitors (SSRIs), certain atypical antipsychotics, and antidepressants have been shown to upregulate BDNF expression indirectly. Regular aerobic exercise is also a powerful, non‑pharmacologic enhancer of BDNF and can improve mood and cognitive function.
Source: MedlinePlus, National Library of Medicine

MedlinePlus brings together authoritative health information from the National Library of Medicine (NLM), the National Institutes of Health (NIH), and other government agencies and health-related organizations.

kontakt@hittavard.se

Ⓒ 2024. Alla rättigheter förbehålls av juxt ab